NASDAQ:CUE
Cue Biopharma, Inc.
- Stock
Last Close
1.74
17/05 20:00
Market Cap
83.18M
Beta: 2.00
Volume Today
116.01K
Avg: 186.50K
PE Ratio
−2.14
PFCF: −2.73
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 112.75K - | 112.75K 0% | 7.56M 6,605.10% | 7.56M 0% | 0.50 - | |||||
average payables | 664.56K - | 1.68M 153.13% | 1.46M 13.27% | 1.48M 1.20% | 2.33M 57.84% | 2.66M 14.18% | 3.12M 17.11% | |||
average receivables | 426.19K - | 426.19K 0% | 377.45K 11.44% | 1.09M 187.77% | 2.28M 109.91% | 1.60M 29.83% | 877.63K 45.14% | |||
book value per share | 0.34 - | 0.74 118.71% | 2.98 305.99% | 1.69 43.47% | 2.48 46.77% | 2.75 11.07% | 2.09 23.89% | 1.84 11.99% | 0.81 56.01% | |
capex per share | -0.04 - | -0.02 31.59% | -0.06 133.53% | -0.09 57.76% | -0.00 97.72% | -0.02 886.66% | -0.03 40.65% | -0.00 83.59% | ||
capex to depreciation | -16.83 - | -2.55 84.83% | -2.87 12.48% | -2.44 15.05% | -0.01 99.63% | -0.56 6,173.14% | 0.51 191.23% | -0.09 118.41% | ||
capex to operating cash flow | 0.46 - | 0.09 81.00% | 0.10 14.32% | 0.07 28.96% | 0.00 97.86% | 0.02 1,117.12% | 0.02 28.33% | 0.00 82.63% | ||
capex to revenue | -1.62 - | -0.01 99.17% | -0.19 1,307.82% | -0.06 67.62% | -0.14 124.39% | |||||
cash per share | 0.31 - | 0.73 132.00% | 3.08 324.57% | 1.95 36.78% | 2.70 38.39% | 2.96 9.76% | 2.06 30.45% | 2.14 4.01% | 1.06 50.45% | |
days of inventory on hand | ||||||||||
days payables outstanding | 371.90 - | |||||||||
days sales outstanding | 79.68 - | 164.02 105.85% | 76.77 53.20% | 16.78 78.14% | 112.89 572.70% | |||||
debt to assets | 0.04 - | 0.08 - | 0.07 11.30% | 0.12 67.89% | 0.21 75.55% | 0.19 11.42% | ||||
debt to equity | 0.04 - | 0.11 - | 0.09 14.71% | 0.15 69.50% | 0.29 91.58% | 0.31 5.75% | ||||
dividend yield | ||||||||||
earnings yield | -0.01 - | -0.03 297.06% | -0.10 203.38% | -0.41 325.60% | -0.10 74.54% | -0.12 18.98% | -0.12 0.02% | -0.52 316.36% | -0.42 19.18% | |
enterprise value | 233.64M - | 225.12M 3.65% | 179.02M 20.48% | 73.83M 58.76% | 311.42M 321.81% | 291.17M 6.50% | 299.52M 2.87% | 69.30M 76.86% | 86.97M 25.50% | |
enterprise value over ebitda | -124.02 - | -30.19 75.66% | -7.85 74.01% | -1.95 75.20% | -8.47 335.21% | -6.62 21.84% | -6.85 3.51% | -1.37 80.08% | -1.79 31.22% | |
ev to operating cash flow | -140.96 - | -37.72 73.24% | -14.68 61.07% | -2.80 80.96% | -10.11 261.74% | -8.96 11.38% | -7.71 13.93% | -1.66 78.51% | -2.18 31.29% | |
ev to sales | 64.62 - | 90.06 39.38% | 92.31 2.50% | 20.05 78.28% | 55.65 177.62% | 15.84 71.53% | ||||
free cash flow per share | -0.12 - | -0.31 168.85% | -0.65 106.60% | -1.40 116.30% | -1.40 0.32% | -1.15 17.57% | -1.27 10.16% | -1.18 7.33% | -0.87 25.83% | |
free cash flow yield | -0.01 - | -0.03 168.85% | -0.06 106.60% | -0.30 435.22% | -0.09 70.49% | -0.09 4.60% | -0.11 21.85% | -0.41 267.77% | -0.33 19.93% | |
graham net net | 0.29 - | 0.67 128.20% | 2.86 325.24% | 1.38 51.65% | 2.29 65.85% | 2.28 0.67% | 1.56 31.45% | 1.42 8.80% | 0.55 61.08% | |
graham number | 0.84 - | 2.48 194.69% | 8.69 250.95% | 8.57 1.40% | 9.63 12.35% | 9.83 2.05% | 8.15 17.04% | 7.84 3.90% | 4.50 42.61% | |
income quality | 0.86 - | 0.78 9.32% | 0.52 32.67% | 0.68 29.12% | 0.84 23.86% | 0.73 13.54% | 0.88 21.21% | 0.79 10.33% | 0.79 0.12% | |
intangibles to total assets | 0 - | 0 | 0.00 Infinity% | 0 100% | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -74.56 - | -41.76 43.99% | ||||||||
interest debt per share | 0.12 - | 0.26 - | 0.25 5.27% | 0.32 29.00% | 0.56 74.85% | 0.28 50.29% | ||||
inventory turnover | ||||||||||
invested capital | 0.04 - | 0.11 - | 0.09 14.71% | 0.15 69.50% | 0.29 91.58% | 0.31 5.75% | ||||
market cap | 240.05M - | 240.05M 0% | 240.05M 0% | 94.63M 60.58% | 349.92M 269.77% | 358.89M 2.57% | 353.84M 1.41% | 101.60M 71.29% | 120.79M 18.89% | |
net current asset value | 6.13M - | 14.03M 128.93% | 59.72M 325.52% | 29.22M 51.07% | 44.00M 50.60% | 66.91M 52.04% | 50.56M 24.43% | 51.59M 2.03% | 27.01M 47.64% | |
net debt to ebitda | 3.40 - | 2.00 41.12% | 2.68 33.64% | 0.55 79.50% | 1.05 90.94% | 1.54 47.06% | 1.24 19.29% | 0.64 48.80% | 0.70 9.48% | |
net income per share | -0.09 - | -0.37 297.06% | -1.13 203.38% | -1.94 71.99% | -1.66 14.00% | -1.56 6.24% | -1.41 9.58% | -1.48 4.92% | -1.11 25.13% | |
operating cash flow per share | -0.08 - | -0.29 260.07% | -0.59 104.27% | -1.31 122.08% | -1.40 6.51% | -1.13 18.93% | -1.24 9.60% | -1.17 5.53% | -0.87 25.52% | |
payables turnover | 0.98 - | |||||||||
receivables turnover | 4.58 - | 2.23 51.42% | 4.75 113.66% | 21.75 357.45% | 3.23 85.13% | |||||
research and ddevelopement to revenue | 24.98 - | 7.95 68.18% | 10.63 33.79% | 2.77 73.98% | 30.98 1,019.54% | 7.34 76.32% | ||||
return on tangible assets | -0.26 - | -0.47 78.42% | -0.35 26.04% | -0.86 146.98% | -0.51 40.36% | -0.45 12.21% | -0.53 17.68% | -0.58 9.23% | -0.82 42.56% | |
revenue per share | 0.06 - | 0.16 176.45% | 0.11 29.92% | 0.48 334.36% | 0.03 92.69% | 0.12 243.51% | ||||
roe | -0.28 - | -0.50 81.55% | -0.38 25.27% | -1.15 204.26% | -0.67 41.41% | -0.57 15.59% | -0.67 18.81% | -0.80 19.21% | -1.37 70.19% | |
roic | -0.28 - | -0.50 81.55% | -0.36 28.19% | -1.16 221.10% | -0.56 51.71% | -0.49 13.60% | -0.52 6.38% | -0.56 8.83% | -1.00 78.65% | |
sales general and administrative to revenue | 9.89 - | 3.68 62.73% | 4.64 26.07% | 1.16 75.06% | 12.98 1,020.99% | |||||
shareholders equity per share | 0.34 - | 0.74 118.71% | 2.98 305.99% | 1.69 43.47% | 2.48 46.77% | 2.75 11.07% | 2.09 23.89% | 1.84 11.99% | 0.81 56.01% | |
stock based compensation to revenue | 6.28 - | 1.89 69.96% | 3.32 76.20% | 0.77 76.80% | 7.63 889.44% | |||||
tangible asset value | 6.94M - | 15.17M 118.71% | 61.43M 304.83% | 33.97M 44.70% | 54.58M 60.68% | 78.91M 44.57% | 65.49M 17.01% | 65.68M 0.29% | 37.09M 43.54% | |
tangible book value per share | 0.34 - | 0.74 118.71% | 2.98 304.83% | 1.69 43.31% | 2.48 46.77% | 2.75 11.07% | 2.09 23.89% | 1.84 11.99% | 0.81 56.01% | |
working capital | 6.16M - | 14.07M 128.25% | 59.72M 324.42% | 34.39M 42.41% | 49.37M 43.54% | 71.21M 44.24% | 55.68M 21.81% | 65.64M 17.89% | 34.37M 47.63% |
All numbers in USD (except ratios and percentages)